Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Integration of pro- and anti-angiogenic signals by endothelial cells.

Kazerounian S, Lawler J.

J Cell Commun Signal. 2018 Mar;12(1):171-179. doi: 10.1007/s12079-017-0433-3. Epub 2017 Dec 20. Review.

2.

Thrombospondin-1, Free Radicals, and the Coronary Microcirculation: The Aging Conundrum.

LeBlanc AJ, Kelm NQ.

Antioxid Redox Signal. 2017 Oct 20;27(12):785-801. doi: 10.1089/ars.2017.7292. Epub 2017 Sep 8. Review.

PMID:
28762749
3.

Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Rogers NM, Ghimire K, Calzada MJ, Isenberg JS.

Cardiovasc Res. 2017 Jul 1;113(8):858-868. doi: 10.1093/cvr/cvx094.

PMID:
28472457
4.

Competitive Protein Binding Influences Heparin-Based Modulation of Spatial Growth Factor Delivery for Bone Regeneration.

Hettiaratchi MH, Chou C, Servies N, Smeekens JM, Cheng A, Esancy C, Wu R, McDevitt TC, Guldberg RE, Krishnan L.

Tissue Eng Part A. 2017 Jul;23(13-14):683-695. doi: 10.1089/ten.tea.2016.0507. Epub 2017 Mar 24.

PMID:
28338419
5.

Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation.

Bazzazi H, Isenberg JS, Popel AS.

Front Physiol. 2017 Feb 6;8:48. doi: 10.3389/fphys.2017.00048. eCollection 2017. Erratum in: Front Physiol. 2017 Mar 07;8:147.

6.

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Rusnati M, Urbinati C, Bonifacio S, Presta M, Taraboletti G.

Pharmaceuticals (Basel). 2010 Apr 23;3(4):1241-1278. Review.

7.

Chronic effects of an anti-angiogenic thrombospondin-1 mimetic peptide, ABT-898, on female mouse reproductive outcomes.

Edwards AK, Olariu I, Nakamura DS, Ahn SH, Tayade C.

Reprod Biol Endocrinol. 2016 Sep 7;14(1):56. doi: 10.1186/s12958-016-0192-7.

8.

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Hamilton JL, Nagao M, Levine BR, Chen D, Olsen BR, Im HJ.

J Bone Miner Res. 2016 May;31(5):911-24. doi: 10.1002/jbmr.2828. Epub 2016 Apr 8. Review.

9.

Matricellular proteins as regulators of cancer metastasis to bone.

Trotter TN, Yang Y.

Matrix Biol. 2016 May-Jul;52-54:301-314. doi: 10.1016/j.matbio.2016.01.006. Epub 2016 Jan 22. Review.

10.

Physiological Capillary Regression is not Dependent on Reducing VEGF Expression.

Olfert IM.

Microcirculation. 2016 Feb;23(2):146-56. doi: 10.1111/micc.12263. Review.

11.

CD47 signaling pathways controlling cellular differentiation and responses to stress.

Soto-Pantoja DR, Kaur S, Roberts DD.

Crit Rev Biochem Mol Biol. 2015;50(3):212-30. doi: 10.3109/10409238.2015.1014024. Epub 2015 Feb 24. Review.

12.
13.

Involvement of TSP1 and MMP9/NGAL in angiogenesis during orthodontic periodontal remodeling.

Surlin P, Silosi I, Rauten AM, Cojocaru M, Foia L.

ScientificWorldJournal. 2014;2014:421029. doi: 10.1155/2014/421029. Epub 2014 May 20.

14.

Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

Rogers NM, Sharifi-Sanjani M, Csányi G, Pagano PJ, Isenberg JS.

Matrix Biol. 2014 Jul;37:92-101. doi: 10.1016/j.matbio.2014.01.002. Epub 2014 Jan 11. Review.

15.

TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.

Yang X, Li P, Yang X, Qin C, Cao Q, Zhang Z, Wang M, Cai H, Gu J, Tao J, Gu M, Lu Q, Yin C.

Int J Genomics. 2013;2013:473242. doi: 10.1155/2013/473242. Epub 2013 Dec 3.

16.

Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Vempati P, Popel AS, Mac Gabhann F.

Cytokine Growth Factor Rev. 2014 Feb;25(1):1-19. doi: 10.1016/j.cytogfr.2013.11.002. Epub 2013 Nov 27. Review.

17.

Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease.

Hoier B, Walker M, Passos M, Walker PJ, Green A, Bangsbo J, Askew CD, Hellsten Y.

J Appl Physiol (1985). 2013 Dec;115(12):1777-87. doi: 10.1152/japplphysiol.00979.2013. Epub 2013 Oct 24.

18.

Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma.

Torimura T, Iwamoto H, Nakamura T, Koga H, Ueno T, Kerbel RS, Sata M.

Transl Oncol. 2013 Oct 1;6(5):511-9. eCollection 2013. Review.

19.

Pregnancy-associated genes contribute to antiluteolytic mechanisms in ovine corpus luteum.

Romero JJ, Antoniazzi AQ, Smirnova NP, Webb BT, Yu F, Davis JS, Hansen TR.

Physiol Genomics. 2013 Nov 15;45(22):1095-108. doi: 10.1152/physiolgenomics.00082.2013. Epub 2013 Sep 17.

20.

The role of platelets in tumour growth.

Pilatova K, Zdrazilova-Dubska L, Klement GL.

Klin Onkol. 2012;25 Suppl 2:2S50-7. Review.

Supplemental Content

Support Center